We demonstrated that miR‐497 could regulate TMZ resistance in glioma cells by promoting cell proliferation and inhibiting apoptosis, at least partially, via targeting the IGF1R/IRS1 pathway. This evidence concerns the gene IGF1R and central nervous system cancer.